Vaccine News and Research

Latest Vaccine News and Research

Call for herpes simplex virus control measures for prevention of HIV transmission

Experts call for HSV control measures, including vaccine, to rank high on international HIV prevention and research agenda as exciting trial findings are published.

22 Feb 2007

Blueprint for influenza pandemic

The American Public Health Association (APHA) today released its blueprint for strengthening the nation's pandemic preparedness, amid persistent concerns about a potential influenza pandemic.

22 Feb 2007

Some health experts concerned proponents of mandatory HPV vaccination are acting too soon

Some public health experts recently have expressed concern that proponents of human papillomavirus vaccination legislation -- including Merck, producer of the HPV vaccine Gardasil -- have acted "far too fast" and are "potentially undermining eventual prospects for the broadest possible immunization," the New York Times reports .

22 Feb 2007

Merck pledges to stop lobbying States on Gardasil

Merck has decided to suspend its campaign to lobby for state proposals that would mandate girls receive its human papillomavirus vaccine Gardasil in light of opposition from some parents, patient advocacy groups and public health officials, the Wall Street Journal reports.

22 Feb 2007

Gates Foundation, Canadian Government announce initiative to develop HIV/AIDS vaccine

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports.

21 Feb 2007

Merck conducts trial of experimental HIV vaccine among sex workers in the Dominican Republic

The pharmaceutical company Merck is conducting Phase II clinical trials of its experimental HIV vaccine among 175 commercial sex workers in the Dominican Republic, the AP/Long Island Newsday reports.

21 Feb 2007

Experimental vector vaccine reduces stillbirths from cytomegalovirus

Researchers funded by the National Institutes of Health have developed an experimental vaccine that reduces stillbirths among rodents born to mothers infected with cytomegalovirus (CMV) - a common virus that can also cause mental retardation and hearing loss in newborn children who were infected in early fetal life.

21 Feb 2007

Entire genetic blueprints of more than 2,000 human and avian influenza viruses completed and made public

The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), announced today that it has achieved a major milestone.

21 Feb 2007

Imaging of disease dynamics during meningococcal sepsis

Each year 170,000 people around the world die of this type of meningitis, according to the World Health Organization, (WHO).

21 Feb 2007

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007

Chemotherapy drug bortezomib packs a one-two punch

Cancer can be wily, and those who treat the disease have amassed a wide array of weapons with which to fight it and kill tumors.

20 Feb 2007

Transmission of drug-resistant tuberculosis among treated patients in Shanghai

A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance.

20 Feb 2007

Expert questions validity of genetic testing patents

Molecular Pathologist-Attorney Roger D. Klein in a letter published in the February 15, 2007 issue of the New England Journal of Medicine questioned the validity of patents often used to prevent clinical laboratories from performing certain genetic tests.

20 Feb 2007

Thimerosal to be discussed at Wednesday's CDC meeting

The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am.

19 Feb 2007

Search for vaccine to prevent Chlamydia

It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.

19 Feb 2007

Scientists discover vulnerable area on HIV that could lead to development of HIV/AIDS vaccine

Scientists on Wednesday announced they had identified a vulnerable area on HIV that might be susceptible to antibodies and could prevent the virus from infecting human cells, Reuters Health reports. The findings are published in the Feb. 15 issue of the journal Nature.

19 Feb 2007

The present and future for influenza vaccines

The near inevitability that influenza will explode into a pandemic in the coming few years has kept researchers searching for a way to prevent the worst effects of infection. The ultimate prize is a highly effective vaccine that could be produced and deployed rapidly.

18 Feb 2007

Novel spray method for delivering tuberculosis vaccine

Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.

18 Feb 2007

Promising results on avian influenza vaccines

Experts meeting this week at the World Health Organization (WHO) on advances in pandemic influenza vaccine development reported encouraging progress.

18 Feb 2007

Nasal spray vaccine gives kids more protection from flu than shots

In a new study involving thousands of children across the world, a new version of the nasal spray vaccine FluMist has been found to be more effective at preventing influenza than traditional flu shots.

18 Feb 2007